THIOREDOXIN-INTERACTING PROTEIN: A CRITICAL LINK BETWEEN GLUCOSE TOXICITY AND BETA CELL APOPTOSIS
- Junqin Chen, PhD1,
- Geetu Saxena, PhD1,
- Imran N. Mungrue, PhD2,
- Aldons J. Lusis, PhD2 and
- Anath Shalev, MD (as7{at}medicine.wisc.edu)1
- 1Department of Medicine, University of Wisconsin, Madison, WI 53792
- 2Department of Medicine, University of California, Los Angeles, CA 90095
Abstract
Objective: In diabetes, glucose-toxicity affects different organ systems including pancreatic islets where it leads to beta cell apoptosis, but the mechanisms are not fully understood. Recently, we identified thioredoxin-interacting protein (TXNIP) as a pro-apoptotic beta cell factor that is induced by glucose raising the possibility that TXNIP may play a role in beta cell glucose-toxicity.
Resarch Design And Methods: To assess the effects of glucose on TXNIP expression and apoptosis and define the role of TXNIP, we used INS-1 beta cells, primary mouse islets, obese, diabetic BTBR.ob mice and a unique mouse model of TXNIP-deficiency (HcB-19) harboring a natural nonsense mutation in the TXNIP gene.
Results: Incubation of INS-1 cells at 25mM glucose for 24h led to a 18-fold increase in TXNIP protein as assessed by immunoblotting. This was accompanied by increased apoptosis as demonstrated by a 12-fold induction of cleaved caspase-3. Overexpression of TXNIP revealed that TXNIP induces the intrinsic mitochondrial pathway of apoptosis. Islets of diabetic BTBR.ob mice also demonstrated increased TXNIP and apoptosis as did isolated wild-type islets incubated at high glucose. In contrast, TXNIP-deficient HcB-19 islets were protected against glucose-induced apoptosis as measured by TUNEL and caspase-3, indicating that TXNIP is a required causal link between glucose-toxicity and beta cell death.
Conclusions: These findings shed new light onto the molecular mechanisms of beta cell glucose-toxicity and apoptosis, demonstrate that TXNIP induction plays a critical role in this vicious cycle and suggest that inhibition of TXNIP may represent a novel approach to reduce glucotoxic beta cell loss.
Footnotes
-
- Received May 25, 2007.
- Accepted December 23, 2007.
- Copyright © American Diabetes Association











